Latest news with #UdayanGuha
Time of India
6 days ago
- Politics
- Time of India
7 held for attack on Suvendu's convoy in Cooch Behar
1 2 Kolkata/Jalpaiguri: Seven people were arrested by Cooch Behar Police on Wednesday in connection with the attack on the convoy of Bengal leader of opposition Suvendu Adhikari. Sources said the arrested included TMC workers and Trinamool Yuva functionaries. The arrested were remanded to five days' judicial custody. Meanwhile, Bengal BJP president Samik Bhattacharya moved a notice in Rajya Sabha under Rule 267 of the Rules of Procedure and Conduct of Business in the Council of State (Rajya Sabha), seeking a discussion on the attack, which he described as "an attack on democracy". Adhikari's convoy came under attack in Cooch Behar on Tuesday, when he arrived to attend a protest rally and submit a memorandum to the SP regarding alleged assaults on BJP workers. As the convoy reached Khagrabari, a group of alleged TMC supporters attacked the convoy. In his complaint, Adhikari named 41 persons, including state minister, Udayan Guha. "We are not going to leave them. If Udayan Guha was directly involved in the incident, the police's role cannot be ruled out," Adhikari said at a meeting on Wednesday. You Can Also Check: Kolkata AQI | Weather in Kolkata | Bank Holidays in Kolkata | Public Holidays in Kolkata According to an agency report, Union home minister Amit Shah spoke to Nisith Pramanik, former Union Minister of state for home affairs, seeking details about the incident. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Live Your Best Life: The 20 Top-Ranked Cities to Move to in 2024 Learn More Undo Guha said the identities of those arrested demonstrate that the allegations made by Adhikari — that the attack on his convoy was carried out by illegal Rohingya and Bangladeshi infiltrators — are unfounded. "Not a single Rohingya or Bangladeshi Muslim was named in complaint or arrested. His comments were baseless and he should apologise. Those who disrespect Bengalis and the Bengali language will be shown black flags," Guha said.
Hindustan Times
06-08-2025
- Politics
- Hindustan Times
'All of them are Bangladeshi Muslims': Suvendu Adhikari on Cooch Behar convoy attack
West Bengal Assembly Leader of Opposition Suvendu Adhikari on Tuesday alleged that his convoy was attacked in Cooch Behar district, and claimed the situation was grave enough that he might not have survived had he not been travelling in a bulletproof vehicle. Adhikari's reaction comes after his convoy of was allegedly attacked in Cooch Behar on Tuesday.(PTI) He alleged that the attackers were "Bangladeshi Muslims" and described them as "arrogant." "I was in a bulletproof car, else you would have seen me in the postmortem house. The situation was very bad. They even broke the glass of bulletproof car. All of them are Bangladeshi Muslims, arrogant," Adhikari told reporters. Adhikari's reaction comes after his convoy of was allegedly attacked in Cooch Behar on Tuesday while he was on his way to meet the Superintendent of Police. Speaking to reporters, Adhikari said, "The Court had granted permission for the LoP and five MLAs to meet the SP. During our arrival, and later in Khagarabari, my convoy was attacked under the leadership of Udayan Guha (TMC leader), a state minister, and in the presence of police. I was with Nishith Pramanik in his bulletproof car, which was completely damaged in an attempt to kill me. Udayan Guha is solely responsible for this, and SP Dyutiman Bhattacharya has helped him in this... They brought in Rohingyas and Bangladeshi Muslims to attack us. After Bihar, SIR will be done in West Bengal too... I will see Udayan Guha and Dyutiman Bhattacharya in Court." He further alleged that democracy had "collapsed" in West Bengal. "They brought in the Rohingyas and Bangladeshi Muslims to attack us. They were brought to Khagarabari. In Bihar, SIR was conducted, and they came to know that it would be done in West Bengal, so I was attacked. Cooch Behar is located near the Bangladesh border, and I raised my voice to remove the intruders, so I was attacked," he added.
India.com
06-07-2025
- Politics
- India.com
Udayan Guha: সিতাইয়ের সভা থেকে উদয়নের হুমকি, কী বলছেন বিজেপি রাজ্য সভাপতি?
Videos Udayan Guha: সিতাইয়ের সভা থেকে উদয়নের হুমকি, কী বলছেন বিজেপি রাজ্য সভাপতি? | Zee 24 Ghanta Udayan Guha: Udayan's Threat from Sitai Rally — What Says the BJP State President? Udayan Guha: Udayan's Threat from Sitai Rally — What Says the BJP State President? | Updated: Jul 06, 2025, 09:50 PM IST Advertisement Udayan Guha: Udayan's Threat from Sitai Rally — What Says the BJP State President?
Yahoo
30-05-2025
- Business
- Yahoo
NextCure, Inc. (NXTC) and LCB to Unveil Promising Preclinical Data on B7-H4 ADC at AACR 2024
NextCure, Inc. (NASDAQ:NXTC) and LigaChem Biosciences, Inc. are set to present new clinical data on their novel cancer therapy, LNCB74, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on June 2, 2025. LNCB74 is a first-in-human, B7-H4 targeted antibody-drug conjugate (ADC) currently being evaluated in a Phase 1 trial for patients with advanced solid tumors, including platinum-resistant ovarian, treatment-refractory breast, endometrial, biliary tract, and squamous non-small cell lung cancers. A scientist in a lab researching the biology of a cancer cell. The ongoing study is in the dose escalation phase and will also include randomized dose expansion and optimization, with an emphasis on safety and biomarker analysis. B7-H4, the ADC's target, is highly expressed in several tumor types but limited in normal tissues, making it an appealing candidate for targeted therapy. According to NextCure, Inc. (NASDAQ:NXTC)'s Chief Medical Officer, Dr. Udayan Guha, LNCB74 has shown a superior safety profile and potent anti-tumor activity in preclinical models. The poster, abstract TPS3167, will be featured during the 'Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology' session. NXTC closed nearly 6% higher on May 29. While we acknowledge the potential of NXTC to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NXTC and that has 100x upside potential, check out our report about this READ NEXT: and Disclosure: None.
Yahoo
30-05-2025
- Business
- Yahoo
NextCure, Inc. (NXTC) and LCB to Unveil Promising Preclinical Data on B7-H4 ADC at AACR 2024
NextCure, Inc. (NASDAQ:NXTC) and LigaChem Biosciences, Inc. are set to present new clinical data on their novel cancer therapy, LNCB74, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on June 2, 2025. LNCB74 is a first-in-human, B7-H4 targeted antibody-drug conjugate (ADC) currently being evaluated in a Phase 1 trial for patients with advanced solid tumors, including platinum-resistant ovarian, treatment-refractory breast, endometrial, biliary tract, and squamous non-small cell lung cancers. A scientist in a lab researching the biology of a cancer cell. The ongoing study is in the dose escalation phase and will also include randomized dose expansion and optimization, with an emphasis on safety and biomarker analysis. B7-H4, the ADC's target, is highly expressed in several tumor types but limited in normal tissues, making it an appealing candidate for targeted therapy. According to NextCure, Inc. (NASDAQ:NXTC)'s Chief Medical Officer, Dr. Udayan Guha, LNCB74 has shown a superior safety profile and potent anti-tumor activity in preclinical models. The poster, abstract TPS3167, will be featured during the 'Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology' session. NXTC closed nearly 6% higher on May 29. While we acknowledge the potential of NXTC to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NXTC and that has 100x upside potential, check out our report about this READ NEXT: and Disclosure: None.
